메뉴 건너뛰기




Volumn 190, Issue , 2016, Pages 111-114

Establishing the cut-off score for remission and severity-ranges on the Psychotic Depression Assessment Scale (PDAS)

Author keywords

Affective disorders; Antidepressive agents; Antipsychotic agents; Psychiatric status rating scales; Psychotic; Remission induction

Indexed keywords

OLANZAPINE; PLACEBO; SERTRALINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

EID: 84945310990     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.09.073     Document Type: Article
Times cited : (16)

References (26)
  • 5
    • 84860591953 scopus 로고    scopus 로고
    • Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment
    • A. Farahani, and C.U. Correll Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment J. Clin. Psychiatry 73 2012 486 496
    • (2012) J. Clin. Psychiatry , vol.73 , pp. 486-496
    • Farahani, A.1    Correll, C.U.2
  • 6
    • 0000238671 scopus 로고
    • Clinical global impressions scale
    • US Department of Health, Education and Welfare/NIMH. Pub no. (AMD) 76-338. Rockville, MD, USA
    • Guy, W., 1976. Clinical global impressions scale. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education and Welfare/NIMH. Pub no. (AMD) 76-338. Rockville, MD, USA.
    • (1976) ECDEU Assessment Manual for Psychopharmacology
    • Guy, W.1
  • 8
    • 84895058430 scopus 로고    scopus 로고
    • Risk factors for suicide among 34,671 patients with psychotic and non-psychotic severe depression
    • A.K. Leadholm, A.J. Rothschild, J. Nielsen, P. Bech, and S.D. Ostergaard Risk factors for suicide among 34,671 patients with psychotic and non-psychotic severe depression J. Affect. Disord. 156 2014 119 125
    • (2014) J. Affect. Disord. , vol.156 , pp. 119-125
    • Leadholm, A.K.1    Rothschild, A.J.2    Nielsen, J.3    Bech, P.4    Ostergaard, S.D.5
  • 11
    • 68149125187 scopus 로고    scopus 로고
    • A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: The study of pharmacotherapy of psychotic depression (STOP-PD)
    • B.S. Meyers, A.J. Flint, A.J. Rothschild, B.H. Mulsant, E.M. Whyte, C. Peasley-Miklus, E. Papademetriou, A.C. Leon, M. Heo, and STOP-PD Group A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD) Arch. Gen. Psychiatry 66 2009 838 847
    • (2009) Arch. Gen. Psychiatry , vol.66 , pp. 838-847
    • Meyers, B.S.1    Flint, A.J.2    Rothschild, A.J.3    Mulsant, B.H.4    Whyte, E.M.5    Peasley-Miklus, C.6    Papademetriou, E.7    Leon, A.C.8    Heo, M.9    Group, S.10
  • 13
    • 84889821927 scopus 로고    scopus 로고
    • Persistent delusional theme over 13 episodes of psychotic depression
    • S.D. Ostergaard, A.K. Leadholm, and A.J. Rothschild Persistent delusional theme over 13 episodes of psychotic depression Acta Neuropsychiatr. 25 2013 370 373 10.1017/neu.2013.33
    • (2013) Acta Neuropsychiatr. , vol.25 , pp. 370-373
    • Ostergaard, S.D.1    Leadholm, A.K.2    Rothschild, A.J.3
  • 14
    • 84898776745 scopus 로고    scopus 로고
    • Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: Implications for the Research Domain Criteria (RDoC)
    • S.D. Ostergaard, P. Bech, M.H. Trivedi, S.R. Wisniewski, A.J. Rush, and M. Fava Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: implications for the Research Domain Criteria (RDoC) J. Affect. Disord. 163 2014 18 24
    • (2014) J. Affect. Disord. , vol.163 , pp. 18-24
    • Ostergaard, S.D.1    Bech, P.2    Trivedi, M.H.3    Wisniewski, S.R.4    Rush, A.J.5    Fava, M.6
  • 16
    • 84898596252 scopus 로고    scopus 로고
    • Measuring treatment response in psychotic depression: The Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account
    • S.D. Ostergaard, B.S. Meyers, A.J. Flint, B.H. Mulsant, E.M. Whyte, C.M. Ulbricht, P. Bech, A.J. Rothschild, and STOP-PD Study Group Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account J. Affect. Disord. 160 2014 68 73
    • (2014) J. Affect. Disord. , vol.160 , pp. 68-73
    • Ostergaard, S.D.1    Meyers, B.S.2    Flint, A.J.3    Mulsant, B.H.4    Whyte, E.M.5    Ulbricht, C.M.6    Bech, P.7    Rothschild, A.J.8    Study Group, S.9
  • 17
  • 20
    • 0000503515 scopus 로고
    • The brief psychiatric rating scale
    • J.E. Overall, and D.R. Gorham The brief psychiatric rating scale Psychol. Rep. 10 1962 799 812
    • (1962) Psychol. Rep. , vol.10 , pp. 799-812
    • Overall, J.E.1    Gorham, D.R.2
  • 22
    • 84918539150 scopus 로고    scopus 로고
    • Is the BPRS-5 subscale of the psychotic depression assessment scale a reliable screening tool for psychotic depression?: Results from the CRESCEND study
    • S.C. Park, S.D. Ostergaard, J. Choi, J.M. Kim, T.Y. Jun, M.S. Lee, J.B. Kim, H.W. Yim, and Y.C. Park Is the BPRS-5 subscale of the psychotic depression assessment scale a reliable screening tool for psychotic depression?: Results from the CRESCEND study J. Affect. Disord. 174C 2014 188 191
    • (2014) J. Affect. Disord. , vol.174 C , pp. 188-191
    • Park, S.C.1    Ostergaard, S.D.2    Choi, J.3    Kim, J.M.4    Jun, T.Y.5    Lee, M.S.6    Kim, J.B.7    Yim, H.W.8    Park, Y.C.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.